Cargando…

Advances in new psychoactive substances identification: the U.R.I.To.N. Consortium

Identification of new psychoactive substances (NPS) in biological and non-biological samples represents a hard challenge for forensic toxicologists. Their great chemical variety and the speed with which new NPS are synthesised and spread make stringent the need of advanced tools for their detection...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertol, Elisabetta, Vaiano, Fabio, Mari, Francesco, Di Milia, Maria Grazia, Bua, Silvia, Supuran, Claudiu T., Carta, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445230/
https://www.ncbi.nlm.nih.gov/pubmed/28629236
http://dx.doi.org/10.1080/14756366.2017.1333987
_version_ 1783408162536161280
author Bertol, Elisabetta
Vaiano, Fabio
Mari, Francesco
Di Milia, Maria Grazia
Bua, Silvia
Supuran, Claudiu T.
Carta, Fabrizio
author_facet Bertol, Elisabetta
Vaiano, Fabio
Mari, Francesco
Di Milia, Maria Grazia
Bua, Silvia
Supuran, Claudiu T.
Carta, Fabrizio
author_sort Bertol, Elisabetta
collection PubMed
description Identification of new psychoactive substances (NPS) in biological and non-biological samples represents a hard challenge for forensic toxicologists. Their great chemical variety and the speed with which new NPS are synthesised and spread make stringent the need of advanced tools for their detection based on multidisciplinary approaches. For this reason, in August 2016, the “Unit of Research and Innovation in Forensic Toxicology and Neuroscience of Addiction” (U.R.I.To.N.) was founded by the Forensic Toxicology Division of the University of Florence. In this Research Unit, various professionals (i.e. forensic toxicologists, chemists, physicians) collaborate to study all the aspects of drugs of abuse, especially NPS. Herein, we describe the multidisciplinary approach comprising liquid chromatography coupled to tandem mass spectrometry (LC–MS/MS), gas chromatography hyphenated to mass spectrometry (GC–MS) and solution nuclear magnetic resonance analysis that allowed the identification of three NPS such as 1-(benzofuran-5-yl)-N-methylpropan-2-amine, 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethan-1-one (bk-2C-B), and 3-(2-aminopropyl)indole (α-methyltryptamine) in seized materials.
format Online
Article
Text
id pubmed-6445230
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-64452302019-04-09 Advances in new psychoactive substances identification: the U.R.I.To.N. Consortium Bertol, Elisabetta Vaiano, Fabio Mari, Francesco Di Milia, Maria Grazia Bua, Silvia Supuran, Claudiu T. Carta, Fabrizio J Enzyme Inhib Med Chem Research Paper Identification of new psychoactive substances (NPS) in biological and non-biological samples represents a hard challenge for forensic toxicologists. Their great chemical variety and the speed with which new NPS are synthesised and spread make stringent the need of advanced tools for their detection based on multidisciplinary approaches. For this reason, in August 2016, the “Unit of Research and Innovation in Forensic Toxicology and Neuroscience of Addiction” (U.R.I.To.N.) was founded by the Forensic Toxicology Division of the University of Florence. In this Research Unit, various professionals (i.e. forensic toxicologists, chemists, physicians) collaborate to study all the aspects of drugs of abuse, especially NPS. Herein, we describe the multidisciplinary approach comprising liquid chromatography coupled to tandem mass spectrometry (LC–MS/MS), gas chromatography hyphenated to mass spectrometry (GC–MS) and solution nuclear magnetic resonance analysis that allowed the identification of three NPS such as 1-(benzofuran-5-yl)-N-methylpropan-2-amine, 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethan-1-one (bk-2C-B), and 3-(2-aminopropyl)indole (α-methyltryptamine) in seized materials. Taylor & Francis 2017-06-20 /pmc/articles/PMC6445230/ /pubmed/28629236 http://dx.doi.org/10.1080/14756366.2017.1333987 Text en © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Bertol, Elisabetta
Vaiano, Fabio
Mari, Francesco
Di Milia, Maria Grazia
Bua, Silvia
Supuran, Claudiu T.
Carta, Fabrizio
Advances in new psychoactive substances identification: the U.R.I.To.N. Consortium
title Advances in new psychoactive substances identification: the U.R.I.To.N. Consortium
title_full Advances in new psychoactive substances identification: the U.R.I.To.N. Consortium
title_fullStr Advances in new psychoactive substances identification: the U.R.I.To.N. Consortium
title_full_unstemmed Advances in new psychoactive substances identification: the U.R.I.To.N. Consortium
title_short Advances in new psychoactive substances identification: the U.R.I.To.N. Consortium
title_sort advances in new psychoactive substances identification: the u.r.i.to.n. consortium
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445230/
https://www.ncbi.nlm.nih.gov/pubmed/28629236
http://dx.doi.org/10.1080/14756366.2017.1333987
work_keys_str_mv AT bertolelisabetta advancesinnewpsychoactivesubstancesidentificationtheuritonconsortium
AT vaianofabio advancesinnewpsychoactivesubstancesidentificationtheuritonconsortium
AT marifrancesco advancesinnewpsychoactivesubstancesidentificationtheuritonconsortium
AT dimiliamariagrazia advancesinnewpsychoactivesubstancesidentificationtheuritonconsortium
AT buasilvia advancesinnewpsychoactivesubstancesidentificationtheuritonconsortium
AT supuranclaudiut advancesinnewpsychoactivesubstancesidentificationtheuritonconsortium
AT cartafabrizio advancesinnewpsychoactivesubstancesidentificationtheuritonconsortium